“Prozac is what I call the Big Bang of pharmaceutical naming. It came out of nowhere, it means absolutely nothing, and it really just said, ‘Wow, OK, this is blockbuster naming in the drug world’,” Scott Piergrossi, vice president of creative development at the Brand Institute, tells CNN.
